Aquestive Therapeutics, Inc. AQST Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accumulated depreciation?
- Aquestive Therapeutics, Inc. (AQST) reported accumulated depreciation of $44.13M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s accumulated depreciation changed year-over-year?
- Aquestive Therapeutics, Inc.'s accumulated depreciation increased by 1.1% year-over-year, from $43.63M to $44.13M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s accumulated depreciation has grown at a 1.5% compound annual growth rate (CAGR), from $40.88M to $44.02M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.